June 7, 2011 - Digirad and Dilon Diagnostics announced that Digirad has contributed advanced photodetector technology for use in Dilon’s newest gamma camera, the U.S. Food and Drug Administration (FDA)-cleared Dilon 6800 Acella, via a technology development and OEM agreement. The new camera, which is being debuted at the 2011 Society of Nuclear Medicine Meeting in San Antonio, Texas, features the largest molecular breast imaging platform on the market, making Dilon the first company in the industry to offer customers a choice in detector sizes.
The introduction of the new Dilon imaging system marks the launch of commercial activities associated with the development agreement between the two companies that commenced in mid- 2010.
Dilon Diagnostics Chairman and CEO Robert G. Moussa said, "The standard Dilon 6800, and the Acella version of it, now provide detectors that are 6 x 8 inches and 8 x 10 inches, respectively, and both are optimized for breast imaging.”
For more information: www.digirad.com, www.dilon.com
October 30, 2026 
